Why Universal Technical Institute is on investors’ radar

Universal Technical Institute (UTI) has been drawing fresh attention after a strong past 3 months, with the stock showing a 39.07% total return and year to date and 1 year figures also in positive territory.

That price action sits alongside reported annual revenue of US$868.986m and net income of US$42.679m. This gives investors concrete numbers to weigh against the company’s recent value score of 1 and its current market value of about US$2.03b.

The recent share price has cooled slightly, with a 7 day share price return of 5.44% and a 30 day share price return decline of 2.20%, but the 90 day share price return of 39.07% and very large 3 year total shareholder return suggest momentum has been building over a longer period.

If UTI’s move has you thinking about what else is out there, this is a good moment to broaden your search with a screener of 18 top founder-led companies

With UTI trading at US$35.49, showing an intrinsic value gap of about 0.2% and sitting roughly 20% below analyst targets, it raises the real question: is there still a buying opportunity here, or is the market already pricing in future growth?

Preferred P/E of 45.8x: Is it justified?

Universal Technical Institute is currently trading on a P/E of 45.8x, which is high relative to both its own estimated fair P/E and its Consumer Services peers.

The P/E ratio compares the company’s share price with its earnings per share. A higher P/E generally means investors are paying more today for each dollar of current earnings. For an education provider that is now profitable and reporting net income of $42.679m on revenue of $868.986m, that kind of multiple suggests the market is placing meaningful weight on future earnings rather than current profitability alone.

Against that backdrop, UTI’s P/E of 45.8x looks expensive when set beside the estimated fair P/E of 26.3x. This is a level the market could move toward if expectations cool. It also stands well above the US Consumer Services industry average of 16.3x and the peer average of 26.3x, indicating investors are pricing in much stronger earnings potential than is reflected in the broader group.

Result: Price-to-Earnings of 45.8x (OVERVALUED)

However, recent 7 day and 30 day share price declines, alongside a value score of 1, indicate that expectations are already high and could reset quickly.

Another view on value: what the DCF says

While the 45.8x P/E suggests UTI is expensive, our DCF model tells a calmer story. The share price of $35.49 is very close to an estimated future cash flow value of $35.57. That tiny gap points to a stock that already reflects much of what the model assumes, so where could the next surprise come from?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Universal Technical Institute for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on valuation and sentiment, this is the moment to look closely at the numbers yourself and decide how comfortable you are with both the upside and the downside. To help you weigh those trade offs quickly, take a closer look at the 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If UTI has grabbed your attention, do not stop there, broaden your watchlist now so you are not late to the next opportunity.

• Target steadier compounding potential by scanning 72 resilient stocks with low risk scores that aim to keep risk scores in check while still offering room for returns.
• Chase strong fundamentals and financial resilience with the solid balance sheet and fundamentals stocks screener (44 results) and see which companies pair healthy balance sheets with solid business models.
• Get ahead of the crowd by checking the screener containing 23 high quality undiscovered gems before they appear on everyone else's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.